Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Net Sales
299.75
181.02
Other Operating Income
0.00
0.00
Total Operating income
299.75
181.02
Raw Material Cost
75.46
47.60
Purchase of Finished goods
38.55
38.63
(Increase) / Decrease In Stocks
4.42
-3.69
Employee Cost
51.28
26.73
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
46.36
27.18
Total Expenditure (Excl Depreciation)
216.07
136.45
Operating Profit (PBDIT) excl Other Income
83.68
44.57
Other Income
8.76
2.34
Operating Profit (PBDIT)
92.44
46.91
Interest
11.24
10.09
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
81.20
36.82
Depreciation
14.09
7.41
Profit Before Tax
67.11
29.41
Tax
15.82
5.46
Provisions and contingencies
0.00
0.00
Profit After Tax
51.29
23.95
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
51.29
23.95
Share in Profit of Associates
0.00
0.00
Minority Interest
0.82
-0.40
Other related items
0.00
0.00
Consolidated Net Profit
52.11
23.55
Equity Capital
46.05
46.05
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
11.32
5.11
Diluted Earnings per share
11.14
7.43
Operating Profit Margin (Excl OI)
30.5%
26.2%
Gross Profit Margin
29.59%
21.65%
PAT Margin
18.69%
14.08%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 112.80%
Standalone Net Profit
Growth in half year ended Sep 2025 is 1,396.72%
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 117.37%
Interest
Growth in half year ended Sep 2025 is 127.21%
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Senores Pharma. With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
299.75
0
299.75
Other Operating Income
0.00
0.00
0.00
Total Operating income
299.75
0
299.75
Raw Material Cost
75.46
0
75.46
Purchase of Finished goods
38.55
0
38.55
(Increase) / Decrease In Stocks
4.42
0
4.42
Employee Cost
51.28
0
51.28
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
46.36
0.00
46.36
Total Expenditure (Excl Depreciation)
216.07
0
216.07
Operating Profit (PBDIT) excl Other Income
83.68
0.00
83.68
Other Income
8.76
0
8.76
Operating Profit (PBDIT)
92.44
0
92.44
Interest
11.24
0
11.24
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
81.20
0
81.20
Depreciation
14.09
0
14.09
Profit Before Tax
67.11
0
67.11
Tax
15.82
0
15.82
Provisions and contingencies
0.00
0
0.00
Profit After Tax
51.29
0
51.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
51.29
0
51.29
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.82
0
0.82
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.11
0
52.11
Equity Capital
46.05
0
46.05
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
11.32
0
11.32
Diluted Earnings per share
11.14
0
11.14
Operating Profit Margin (Excl OI)
30.50%
0%
0.00
30.50%
Gross Profit Margin
29.59%
0%
0.00
29.59%
PAT Margin
18.69%
0%
0.00
18.69%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 36.41 Cr
in Sep 2025Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 9.13 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.37 Cr
in Sep 2025Figures in Cr
Half Yearly - Interest
Interest 3.34 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.02%
in Sep 2025Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
